Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism. [PDF]
Onorati F +5 more
europepmc +1 more source
Exome Sequencing uncovers Homozygous Stop-Gained variant in the <i>SYNE1</i> Gene Leading to Spinocerebellar Ataxia. [PDF]
Haque A +5 more
europepmc +1 more source
Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3. [PDF]
Guo J +11 more
europepmc +1 more source
Therapeutic potential of the Nrf2 activator omaveloxolone in spinocerebellar ataxia type 3 in cellular and <i>Drosophila</i> models. [PDF]
Pan SH +6 more
europepmc +1 more source
IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]
Chiu C +8 more
europepmc +1 more source
Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. [PDF]
Potashman M +14 more
europepmc +1 more source
Domain-dependent uncoupling of the co-chaperone and E3 ubiquitin ligase CHIP underlies heterogeneity in spinocerebellar ataxia 48. [PDF]
Altinok S +22 more
europepmc +1 more source
Mapping the Disrupted Connectome in Spinocerebellar Ataxia Type 3: A Network-Based Statistics Study Identifying Novel Therapeutic Targets for Neuromodulation. [PDF]
Ou L +12 more
europepmc +1 more source
A Rare Case of Spinocerebellar Ataxia 50: The First Reported Case from the Indian Subcontinent with a Review of the Literature. [PDF]
Taparia V, Chawla T, Goyal C, Goyal V.
europepmc +1 more source

